What is Wendy Marlowe?
Wendy Marlowe operates within the specialized field of neuropsychology and behavioral health, focusing on diagnostics and treatment for ADD/ADHD across adolescent and adult populations. The company's services encompass evaluations, psychological testing, and addressing complex issues such as child behavior problems, learning disabilities, and forensic evaluations. Its comprehensive approach aims to provide critical support for individuals facing developmental and behavioral challenges, positioning it as a key player in mental health services.
How much funding has Wendy Marlowe raised?
Wendy Marlowe has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Wendy Marlowe?
The recent influx of substantial expansion capital, indicative of a significant Series B/C stage, suggests Wendy Marlowe is poised for strategic scaling. This funding is likely earmarked for enhancing service delivery, expanding its clinical reach, and potentially investing in advanced diagnostic technologies. The company's focus on critical areas like ADD/ADHD and learning disabilities, coupled with its specialized evaluation services, provides a strong foundation for sustained development and market leadership in the behavioral health sector.
See full Wendy Marlowe company page
